- Home
- MCRI vs CNTA Comparison
MCRI vs CNTA Comparison
Compare MCRI & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRI
- CNTA
- Stock Information
- Founded
- MCRI 1972
- CNTA 2020
- Country
- MCRI United States
- CNTA United Kingdom
- Employees
- MCRI N/A
- CNTA N/A
- Industry
- MCRI Hotels/Resorts
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- MCRI Consumer Discretionary
- CNTA Health Care
- Exchange
- MCRI Nasdaq
- CNTA Nasdaq
- Market Cap
- MCRI 1.6B
- CNTA 1.9B
- IPO Year
- MCRI 1993
- CNTA 2021
- Fundamental
- Price
- MCRI $100.13
- CNTA $16.35
- Analyst Decision
- MCRI Hold
- CNTA Strong Buy
- Analyst Count
- MCRI 5
- CNTA 11
- Target Price
- MCRI $96.20
- CNTA $28.90
- AVG Volume (30 Days)
- MCRI 185.5K
- CNTA 1.1M
- Earning Date
- MCRI 07-16-2025
- CNTA 08-12-2025
- Dividend Yield
- MCRI 1.18%
- CNTA N/A
- EPS Growth
- MCRI N/A
- CNTA N/A
- EPS
- MCRI 4.22
- CNTA N/A
- Revenue
- MCRI $534,693,999.00
- CNTA $15,000,000.00
- Revenue This Year
- MCRI $6.37
- CNTA N/A
- Revenue Next Year
- MCRI $4.55
- CNTA N/A
- P/E Ratio
- MCRI $24.06
- CNTA N/A
- Revenue Growth
- MCRI 4.65
- CNTA 118.88
- 52 Week Low
- MCRI $69.99
- CNTA $9.10
- 52 Week High
- MCRI $113.88
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- MCRI 60.28
- CNTA 58.56
- Support Level
- MCRI $100.13
- CNTA $15.05
- Resistance Level
- MCRI $102.80
- CNTA $17.45
- Average True Range (ATR)
- MCRI 2.86
- CNTA 0.76
- MACD
- MCRI -0.63
- CNTA -0.01
- Stochastic Oscillator
- MCRI 6.47
- CNTA 38.26
About MCRI Monarch Casino & Resort Inc.
Monarch Casino & Resort Inc is engaged in providing the latest gaming, dining, and hospitality amenities. It owns and operates the Atlantis Casino Resort Spa, a hotel/casino facility in Reno, Nevada, and the Monarch Black Hawk Casino in Black Hawk. The company generates the majority of its revenue from Casinos, followed by Food & Beverage and Hotel Operations.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.